Sports cardiology is a field in continuous development, which deals with sensitive issues that require constant scientific updating.
The 19th National Congress of the Italian Society of Sports Cardiology, which was held from June 13 to 15 in the center of Rome, was an extraordinary opportunity to learn, console and update on the latest scientific advances related to diagnosis and therapies of many cardiovascular pathologies related to the world of sports.
Sports medicine in general, and sports cardiology in particular, constitute a true excellence in Italy, often cited as a point of reference in the field of medical sports certification. Therefore, we are grateful to have participated in the congress presenting our portfolio of products, mainly myCardioDNA, the first exome based on a genetic test that analyzes 90 genes related to hereditary heart diseases, and myGenome, the genetic test of complete genome sequencing for healthy patients.
Thanks to knowing the hereditary risk of developing different types of diseases, such as cardiovascular diseases, it enables specialists to carry out specific monitoring of the patient, as well as dealing with preventive options.